ISRCTN ISRCTN12187583
DOI https://doi.org/10.1186/ISRCTN12187583
Protocol serial number RBG 00XX77
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
Funder NHS Executive Trent (UK)
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
09/12/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nigel Sturrock
Scientific

Consultant Physician
Nottingham City Hospital NHS Trust
Hucknall Road
Nottingham
NG5 1PB
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesTo assess the effectiveness of a simple treatment algorithm in primary care in attaining the recommended blood pressure in patients with type 2 diabetes compared to usual practice. To assess the cost-effectiveness of the algorithm for improving blood pressure control in these patients.

Assuming 40% of diabetics have a blood pressure of <140/80 an intracluster correlation coefficient (ICC) of 0.02 and an average cluster size of 45 type 2 diabetics per practice. Based on 80% power and 5% two-sided significance level 388 participants would be required in each arm of the study.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNutritional, metabolic and endocrine diseases: Diabetes
InterventionNot provided at time of registration
Intervention typeOther
Primary outcome measure(s)

Proportion of participants who have achieved good blood pressure control defined as reaching the recommended level of <140/80.

Key secondary outcome measure(s)

Change in blood pressure from baseline, attendance at hypertension review appointments and patient satisfaction with the care received. Both measures will be assessed at 12 months post recruitment to the trial.

Completion date28/02/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Key inclusion criteriaThe study population will comprise all patients with type 2 diabetes on the lists of participating general practitioners who give informed consent to participate in the study.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/03/2001
Date of final enrolment28/02/2003

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Consultant Physician
Nottingham
NG5 1PB
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2007 Yes No